The road to a World Health Organization global action plan on epilepsy and other neurological disorders.
IBE
ILAE
World Health Organization
global action plan on epilepsy
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
04
02
2021
accepted:
08
02
2021
pubmed:
7
3
2021
medline:
1
10
2021
entrez:
6
3
2021
Statut:
ppublish
Résumé
The World Health Organization (WHO) has recognized epilepsy as a public health imperative due to its occurrence at all ages in all regions of the world, its high impact on disability-adjusted life years and psychosocial aspects, and the accompanying stigma. The International League Against Epilepsy and the International Bureau for Epilepsy have established crucial collaborations with regional and global organizations to promote epilepsy as a treatable disease, close the treatment gap in care, education, and research, and eradicate stigma. In November 2020, the efforts of these three organizations-with support from WHO member states, the World Federation of Neurology, and the European Federation of Neurological Associations-culminated in the unanimous approval of a WHO resolution to create and implement an Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders. This unique achievement is built on more than 2 decades of collaboration and effort, and heralds extraordinary opportunities to work toward a world where no person's life is limited by epilepsy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1057-1063Informations de copyright
© 2021 International League Against Epilepsy.
Références
WHA resolution calls for integrated action on epilepsy and other neurological disorders. https://www.who.int/news/item/13-11-2020-wha-resolution-calls-for-integrated-action-on-epilepsy-and-other-neurological-disorders. Accessed 18 Dec 2020.
Epilepsy: a public health imperative. Geneva, Switzerland: WHO; 2019.
Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet. 2012;380(9848):1193-201.
Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci. 1999;26(4):263-70.
Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52(12):2168-80.
Gaitatzis A, Carroll K, Majeed A, Sander W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45(12):1613-22.
Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep. 2014;14(5):444.
Braga P, Hosny H, Kakooza-Mwesige A, Rider F, Tripathi M, Guekht A. How to understand and address the cultural aspects and consequences of diagnosis of epilepsy, including stigma. Epileptic Disord. 2020;22(5):531-47.
Levira F, Thurman DJ, Sander JW, Hauser WA, Hesdorffer DC, Masanja H, et al. Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia. 2017;58(1):6-16.
Thurman DJ, Logroscino G, Beghi E, Hauser WA, Hesdorffer DC, Newton CR, et al. The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia. 2017;58(1):17-26.
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877-97.
Thurman DJ, Hesdorffer DC, French JA. Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia. 2014;55(10):1479-85.
Lowerison MW, Josephson CB, Jetté N, Sajobi TT, Patten S, Williamson T, et al. Association of levels of specialized care with risk of premature mortality in patients with epilepsy. JAMA Neurol. 2019;76(11):1352-8.
Kalilani L, Faught E, Kim H, Burudpakdee C, Seetasith A, Laranjo S, et al. Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US. Neurology. 2019;92(19):e2197-208.
Baulac M, De Boer H, Elger C, Glynn M, Kälviäinen R, Little A, et al. The written declaration on epilepsy: an important achievement for Europe and beyond. Seizure. 2012;21(1):75-6.
Pan American Health Organization/World Health Organization. Strategy and plan of action on epilepsy. 2011. https://www.paho.org/en/documents/strategy-and-plan-action-epilepsy-2011. Accessed 04 Jan 2021.
England MJ, Liverman CT, Schultz AM, Strawbridge LM. Epilepsy across the spectrum-promoting health and understanding. Washington, DC: Institute of Medicine of the National Academies; 2012.
Covanis A, Guekht A, Li S, Secco M, Shakir R, Perucca E. From global campaign to global commitment: the World Health Assembly’s resolution on epilepsy. Epilepsia. 2015;56(11):1651-7. Accessed 18 Dec 2020
World Health Organization, International League Against Epilepsy, International Bureau for Epilepsy. “Out of the shadows” global campaign against epilepsy. Cruquius, the Netherlands: Paswerk Bedrijven; 2001.
Wang W, Wu J, Dai X, Ma G, Yang B, Wang T, et al. Global campaign against epilepsy: assessment of a demonstration project in rural China. Bull World Health Organ. 2008;86(12):964-9.
Mental Health Gap Action Programme (mhGAP). https://www.who.int/teams/mental-health-and-substance-use/mental-health-gap-action-programme. Accessed 04 Jan 2021.
WHA side event: Epilepsy: a public health priority. https://www.ilae.org/ilaephotogallery/wha-side-event-epilepsy-a-public-health-priority. Accessed 04 Jan 2021.